The FDA has rejected AbbVie’s application for its new wrinkle treatment TrenibotE, citing manufacturing deficiencies that must be resolved before approval. In Sacramento County, health inspectors ...

The training is designed for food processors and individuals responsible for developing or overseeing food safety plans.

The proposed spin-out is intended to separate from HYTN a peptide-focused drug development business centered on the pre-clinical development of a subcutaneous injectable BPC-157 drug candidate for ...

The biotech sector is transitioning away from a framework dominated by long-term research spending toward one in which scientific progress can be directly reflected in financial valuation. As drug ...

OrganaBio, LLC ("OrganaBio"), a vertically integrated blood and cell products and services company delivering end-to-end solutions for cell and gene therapy developers, and RxMP Therapeutics, Inc.

The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, has successfully passed the on-site GMP ...

Globally, pharmaceutical-grade ibogaine supply remains limited, fragmented, and largely non-integrated, making access to standardized, GMP-compliant material a critical constraint on clinical progress ...

Trump directed the FDA to expedite reviews of psychedelic medicines, including ibogaine, and committed $50 million in funding for clinical research. ・The company recently produced medical-grade ...

Sponsored by Business Location Switzerland Learnings from Switzerland By Christoph Besmer, US Trade Commissioner for ...

Quality Executive Partners, Inc. ® (QxP), a global leader in pharmaceutical quality, workforce development, regulatory ...

The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good ...